Patient First Maryland Medical Group, PLLC
Patient First Maryland Medical Group, PLLC was paid $19.49M by Medicaid between Sep 2019 and Dec 2024, across 91 billing codes. Its largest line is S9083, Global fee urgent care centers — 68% of everything it billed.
GLEN ALLEN, VA 23060
Next to other Urgent Care Clinic/Center providers in Virginia
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 3,918 | $22K | |
| 2020 | 537,728 | $11.75M | |
| 2021 | 155,341 | $5.59M | |
| 2022 | 37,586 | $1.74M | |
| 2023 | 18,137 | $222K | |
| 2024incomplete | 14,650 | $170K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| S9083 | Global fee urgent care centers | 68% | 152,530 | 119,475 | $13.29M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 93,679 | 72,829 | $2.58M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.0% | 67,390 | 54,937 | $1.75M |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | 3.4% | 21,249 | 17,679 | $661K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 22,640 | 17,914 | $183K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 13,981 | 11,002 | $144K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 17,248 | 13,928 | $113K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 3,016 | 2,852 | $113K |
| 87428 | <1% | 7,809 | 7,295 | $100K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 36,178 | 26,456 | $70K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 23,563 | 18,986 | $60K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 17,218 | 12,275 | $58K |
79 more codes
| 81000 | <1% | 22,038 | $53K | |
| 81002 | <1% | 17,982 | $53K | |
| 93000 | <1% | 7,171 | $40K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 11,512 | $26K |
| 73564 | <1% | 3,224 | $24K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 27,354 | $24K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,382 | $23K |
| 73630 | <1% | 2,662 | $14K | |
| 80047 | <1% | 21,854 | $11K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 52,210 | $10K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,881 | $9K |
| 73610 | <1% | 2,529 | $9K | |
| 73030 | <1% | 1,745 | $7K | |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | <1% | 2,681 | $6K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 831 | $5K |
| 73110 | <1% | 1,401 | $4K | |
| 99058 | <1% | 26,636 | $4K | |
| 99201 | <1% | 2,456 | $3K | |
| 71101 | <1% | 565 | $2K | |
| 87220 | <1% | 11,285 | $2K | |
| 99070 | <1% | 1,582 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,073 | $2K |
| 73130 | <1% | 1,206 | $2K | |
| 81025 | <1% | 10,899 | $2K | |
| A4565 | Slings | <1% | 1,426 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,114 | $2K |
| 99051 | <1% | 6,703 | $2K | |
| 72050 | <1% | 1,219 | $2K | |
| 72110 | <1% | 1,199 | $1K | |
| 85027 | <1% | 1,715 | $1K | |
| 90714 | <1% | 167 | $1K | |
| 73660 | <1% | 610 | $1K | |
| 73502 | <1% | 249 | $1K | |
| 94150 | <1% | 684 | $1K | |
| 73140 | <1% | 1,447 | $1K | |
| 87210 | <1% | 11,202 | $1K | |
| 29125 | <1% | 652 | $949.50 | |
| G0008 | Administration of influenza virus vaccine | <1% | 206 | $949.49 |
| 90686 | <1% | 1,280 | $932.39 | |
| 99205 | Prolong outpt/office vis | <1% | 96 | $775.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,410 | $696.40 |
| 90715 | <1% | 866 | $674.88 | |
| 73080 | <1% | 430 | $549.46 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,172 | $519.62 |
| 85007 | <1% | 1,696 | $495.47 | |
| 10060 | <1% | 315 | $384.94 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 700 | $369.66 |
| 82948 | <1% | 97 | $289.48 | |
| 73590 | <1% | 143 | $212.88 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 444 | $176.78 |
| A6257 | Transparent film, sterile, 16 sq. in. or less, each dressing | <1% | 83 | $154.43 |
| A9273 | Cold or hot fluid bottle, ice cap or collar, heat and/or cold wrap, any type | <1% | 241 | $137.25 |
| 74022 | <1% | 421 | $101.65 | |
| 36416 | <1% | 170 | $100.32 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 368 | $97.01 |
| 84703 | <1% | 887 | $54.67 | |
| 74018 | <1% | 374 | $42.42 | |
| 29515 | <1% | 199 | $40.97 | |
| 73090 | <1% | 56 | $36.30 | |
| 72070 | <1% | 88 | $33.55 | |
| 12001 | <1% | 193 | $29.70 | |
| 86580 | <1% | 1,183 | $26.19 | |
| A4570 | Splint | <1% | 1,007 | $12.00 |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | <1% | 1,010 | $0.08 |
| E0114 | Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips | <1% | 1,651 | $0.07 |
| L3260 | Surgical boot/shoe, each | <1% | 952 | $0.07 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 1,049 | $0.04 |
| L4350 | Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf | <1% | 711 | $0.03 |
| L4360 | Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise | <1% | 136 | $0.02 |
| L0120 | Cervical, flexible, non-adjustable, prefabricated, off-the-shelf (foam collar) | <1% | 29 | $0.02 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 146 | $0.01 |
| 86308 | 0% | 635 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 245 | $0.00 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 0% | 43 | $0.00 |
| 99050 | 0% | 34 | $0.00 | |
| 12002 | 0% | 37 | $0.00 | |
| L1830 | Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf | 0% | 400 | $0.00 |
| 12011 | 0% | 33 | $0.00 | |
| J7510 | Prednisolone oral, per 5 mg | 0% | 77 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.